## Abstract Although many studies have examined the mechanisms of 1,25‐dihydroxyvitamin D~3~ (calcitriol or 1,25 D) action in different prostate cancer cell lines, little is known regarding the influence of this steroid on the normal prostate. The presence of both VDR and AR in normal prostatic tis
Protective role of 1α, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells
✍ Scribed by Bo-Ying Bao; Huei-Ju Ting; Jong-Wei Hsu; Yi-Fen Lee
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 451 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Overproduction of reactive oxygen species (ROS), through either endogenous or exogenous sources, could induce DNA damage, and accumulation of DNA damage might lead to multistep carcinogenesis. The antioxidative effects of vitamin D have been suggested by epidemiological and many in vitro and in vivo laboratory studies. While exploring the antioxidative effects of vitamin D in prostate cells, we found that the active form of vitamin D, 1α, 25‐dihydroxyvitamin D~3~ (1,25‐VD), can protect nonmalignant human prostate epithelial cell lines, BPH‐1 and RWPE‐1, but not malignant human prostate epithelial cells, CWR22R and DU 145, from oxidative stress‐induced cell death. Glucose‐6‐phosphate dehydrogenase (G6PD), a key antioxidant enzyme, was dose‐ and time‐dependently induced by 1,25‐VD. Mechanistic studies using chromatin immunoprecipitation (ChIP) assay revealed that a direct repeat‐3 (DR3) vitamin D response element located in the first intron of the G6PD genome can be bound by liganded vitamin D receptor, thereby regulating G6PD gene expression. Increasing G6PD activity and glutathione level by 1,25‐VD can scavenge cellular ROS. Moreover, the protective effects of 1,25‐VD were abolished by dehydroepiandrosterone, a noncompetitive inhibitor of G6PD activity. Together, our results showed that 1,25‐VD can protect nonmalignant prostate cells from oxidative stress‐induced cell death by elimination of ROS‐induced cellular injuries through transcriptional activation of G6PD activity. The antioxidative effect of vitamin D strengthens its roles in cancer chemoprevention and adds to a growing list of beneficial effects of vitamin D against cancer. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
In this report we describe that 1,25(OH)(2)D(3)-3-BE, a VDR-affinity labeling analog of 1,25(OH)(2)D(3), showed strong and dose-dependent growth-inhibitory effect in several epithelial cells, i.e., keratinocytes (primary cells), MCF-7 breast cancer, PC-3, and LNCaP prostate cancer and PZ-HPV-7 immor
## Abstract The active form of vitamin D, 1α,25‐dihydroxyvitamin D~3~ (1,25(OH)~2~D) inhibits the growth of prostate epithelial cells, however the underlying mechanisms have not been clearly delineated. In the current study, the impact of 1,25(OH)~2~D on the rapid activation of extracellular‐regula
The ability of the hormonally active vitamin D metabolite, Ia,25-dihydroxyvitamin Dj, to affect cell growth, morphology and fibronectin production has been examined using the MG-63 human osteosarcoma cell line. Hormone treatment reduced cell growth rate, saturation density and ['Hlthymidine incorpor
Retinoids and vitamin D analogues are known to inhibit the proliferation of a variety of cells in culture and prevent the formation of certain tumors in mammals. Although it is well established that these hormones control the transcription of many genes upon binding to and activating specific nuclea